These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25331796)

  • 1. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
    Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
    Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
    Kandpal RP
    Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
    Johnson C; Segovia B; Kandpal RP
    Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma.
    Yu J; Bulk E; Ji P; Hascher A; Koschmieder S; Berdel WE; Müller-Tidow C
    Int J Oncol; 2009 Jul; 35(1):175-9. PubMed ID: 19513565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
    Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
    Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
    Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
    Fox BP; Kandpal RP
    Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
    Choi CH; Lee BH; Ahn SG; Oh SH
    Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231.
    Vaira S; Friday E; Scott K; Conrad S; Turturro F
    J Cell Physiol; 2012 Feb; 227(2):578-86. PubMed ID: 21448924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Parshad R; Ralhan R
    BMC Cancer; 2009 Sep; 9():325. PubMed ID: 19751508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of tetrahydropyridinol derivatives on β-catenin signaling and invasion in human hepatocellular and breast carcinoma cells.
    Yadunandam AK; Yoon JS; Jeong YT; Kim WY; Lee SY; Kim GD
    Int J Mol Med; 2015 Aug; 36(2):577-87. PubMed ID: 26059838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells.
    Gupta C; Tikoo K
    J Mol Endocrinol; 2013; 51(1):119-29. PubMed ID: 23690508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
    Fox BP; Kandpal RP
    Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
    Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphB6 receptor modulates micro RNA profile of breast carcinoma cells.
    Bhushan L; Kandpal RP
    PLoS One; 2011; 6(7):e22484. PubMed ID: 21811619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.